INZY

Inozyme Pharma
INZY

Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

53 hedge funds and large institutions have $428M invested in Inozyme Pharma in 2020 Q3 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$67.5M
2
+$64.3M
3
+$53.3M
4
RCM
RA Capital Management
Massachusetts
+$52.7M
5
DM
Deerfield Management
New York
+$30.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$440K
27
$421K
28
$360K
29
$326K
30
$323K
31
$288K
32
$269K
33
$263K
34
$250K
35
$238K
36
$223K
37
$210K
38
$161K
39
$128K
40
$116K
41
$72K
42
$66K
43
$52K
44
$33K
45
$33K
46
$23K
47
$18K
48
$14K
49
$12K
50
$10K
1
2
3